[CRVS] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
01-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 6.20%
YoY- -7.60%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT 27,347 -11,047 -10,509 -11,929 -11,086 -6,039 -154 -
Tax -143 -185 -180 -219 -184 17,600 0 -
NP 27,347 -11,047 -10,509 -11,929 -11,086 -6,039 -154 -
Tax Rate 0.52% - - - - - - -
Total Cost -27,347 11,047 10,509 11,929 11,086 6,039 154 -
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.92 -0.38 -0.36 -0.58 -0.55 -0.68 -0.49 -
EPS Diluted 0.92 -0.38 -0.36 -0.58 -0.55 -0.68 -0.49 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.